Editas Medicine
EDIT
#8542
Rank
A$0.39 B
Marketcap
A$2.56
Share price
-3.39%
Change (1 day)
-34.09%
Change (1 year)

Earnings for Editas Medicine (EDIT)

Earnings in 2026 (TTM): -A$0.11 Billion

According to Editas Medicine 's latest financial reports the company's current earnings are A$47 Million. In 2025 the company made an earning of -A$0.24 Billion, an increase over its 2024 earnings that were of -A$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Editas Medicine from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.11 Billion-55.35%
2025 -A$0.24 Billion-31.93%
2024 -A$0.34 Billion33.62%
2023 -A$0.26 Billion-25.13%
2022 -A$0.34 Billion16.98%
2021 -A$0.29 Billion43.24%
2020 -A$0.21 Billion-4.41%
2019 -A$0.22 Billion24.39%
2018 -A$0.17 Billion-4.98%
2017 -A$0.18 Billion22.73%
2016 -A$0.15 Billion172.88%
2015 -A$53.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-A$3.73 Million-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-A$0.11 Billion 4.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-A$0.34 Billion 219.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-A$0.14 Billion 28.73% Jersey